Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus reuteri UALre-16

Most-studied combinations with Lactobacillus reuteri UALre-16

most supplement research is combination research
  • Low evidence
    withLactobacillus reuteri MAK02L14RforReduced Hospitalization Duration· 3 studies

    Across 3 papers studying the combination of Lactobacillus reuteri MAK02L14R and Lactobacillus reuteri UALre-16 for reduced hospitalization duration, all reported beneficial effects, with 2 of 3 finding statistically significant reductions. Effect sizes were mixed, ranging from small reductions (−0.54 days) in children with acute gastroenteritis to large reductions (−10.77 days) in preterm neonates. These results are similar to the solo syntheses for both strains individually, but the combination evidence is limited by the fact that the studies labeled the intervention generically as 'L. reuteri DSM 17938', making it impossible to attribute effects to the specific combination of MAK02L14R and UALre-16 strains.

Also studied with:Lactobacillus reuteri DSM 17938 (2)
Back to top